Integer Announces CEO Transition, COO Khales to Succeed Dziedzic

Integer Holdings Corp announced that CEO Joseph Dziedzic will retire on October 24, 2025, with current COO Payman Khales set to succeed him; Dziedzic will continue as an advisor until March 2026 to ensure a smooth transition. Khales, who has been with Integer since 2018 and has a strong track record of driving growth in the Cardio & Vascular business, is expected to continue the company's momentum. Under Dziedzic's leadership, Integer experienced significant growth and value creation, and the company remains well-positioned for continued margin expansion and above-market organic sales growth. The leadership transition comes as Integer reported robust Q1 2025 financial results, including 7% year-over-year sales growth and a 15% increase in adjusted earnings per share. The succession plan is viewed positively, though analysts note potential short-term uncertainties as Khales assumes his new responsibilities. Investors are encouraged to monitor how the new CEO navigates the evolving medical device market and maintains strategic direction.